|
Martinez-Montesinos L, Rivera-Caravaca JM, Agewall S, Soler E, Lip GYH, Marin F, Roldan V. Polypharmacy and adverse events in atrial fibrillation: Main cause or reflection of multimorbidity? Biomed Pharmacother. 2023 Feb;158:114064. doi: 10.1016/j.biopha.2022.114064. Epub 2022 Dec 7. PubMed PMID: 36495662.
AÑO: 2023; IF: 7.5
|
36495662
|
Lopez-Galvez R, Rivera-Caravaca JM, Roldan V, Orenes-Pinero E, Esteve-Pastor MA, Lopez-Garcia C, Saura D, Gonzalez J, Lip GYH, Marin F. Imaging in atrial fibrillation: A way to assess atrial fibrosis and remodeling to assist decision-making. Am Heart J. 2023 Apr;258:1-16. doi: 10.1016/j.ahj.2022.12.007. Epub 2022 Dec 13. PubMed PMID: 36526006.
AÑO: 2023; IF: 3.7
|
|
Nadarajah R, Ludman P, Appelman Y, Brugaletta S, Budaj A, Bueno H, Huber K, Kunadian V, Leonardi S, Lettino M, Milasinovic D, Gale CP; NSTEMI Investigators. Cohort profile: the ESC EURObservational Research Programme Non-ST-segment elevation myocardial infraction (NSTEMI) Registry. Eur Heart J Qual Care Clin Outcomes. 2022 Dec 13;9(1):8-15. doi: 10.1093/ehjqcco/qcac067. PubMed PMID: 36259751.
AÑO: 2022; IF: 5.2
|
|
Lopez-Galvez R, Rivera-Caravaca JM, Mandaglio-Collados D, Orenes-Pinero E, Lahoz A, Hernandez-Romero D, Martinez CM, Carpes M, Arribas JM, Canovas S, Lip GYH, Marin F. Molecular mechanisms of postoperative atrial fibrillation in patients with obstructive sleep apnea. FASEB J. 2023 Jun;37(6):e22941. doi: 10.1096/fj.202201965RR. PubMed PMID: 37115741.
AÑO: 2023; IF: 4.4
|
|
Mandaglio-Collados D, Lopez-Galvez R, Ruiz-Alcaraz AJ, Lopez-Garcia C, Roldan V, Lip GYH, Marin F, Rivera-Caravaca JM. Impact of particulate matter on the incidence of atrial fibrillation and the risk of adverse clinical outcomes: A review. Sci Total Environ. 2023 Jul 1;880:163352. doi: 10.1016/j.scitotenv.2023.163352. Epub 2023 Apr 4. PubMed PMID: 37023806.
AÑO: 2023; IF: 8.2
|